Page last updated: 2024-12-05

2'-hydroxyacetophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2'-hydroxyacetophenone, also known as o-hydroxyacetophenone, is a aromatic ketone. It is a colorless to pale yellow liquid with a characteristic sweet odor. It is used as an intermediate in the synthesis of pharmaceuticals, dyes, and other organic compounds. 2'-hydroxyacetophenone is a versatile building block for organic synthesis, and it is used in the preparation of various organic compounds. 2'-hydroxyacetophenone can be prepared by the Friedel-Crafts acylation of phenol with acetyl chloride in the presence of a Lewis acid catalyst. 2'-hydroxyacetophenone exhibits a range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. It has also been shown to have antioxidant and neuroprotective effects. As a result, it is being investigated for its potential therapeutic applications. 2'-hydroxyacetophenone is being studied for its potential applications in organic synthesis, medicine, and materials science.'

2-acetylphenol : A monohydroxyacetophenone that is acetophenone in which one of the hydrogens ortho to the acetyl group has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8375
CHEMBL ID3187012
CHEBI ID145716
SCHEMBL ID40865
MeSH IDM0232734

Synonyms (99)

Synonym
nsc 16933
einecs 204-288-0
2-hydroxyphenyl methyl ketone
fema no. 3548
ai3-12134
brn 0386123
methyl 2-hydroxyphenyl ketone
nsc-44452
nsc44452
118-93-4
usaf ke-20
o-acetylphenol
nsc16933
ethanone, 1-(2-hydroxyphenyl)-
wln: qr bv1
2'-hydroxyacetophenone
acetophenone, 2'-hydroxy-
nsc-9263
2-acetylphenol
o-hydroxyphenyl methyl ketone
acetophenone, o-hydroxy-
nsc-16933
nsc9263
o-hydroxyacetophenone
acetophenone,2-hydroxy
inchi=1/c8h8o2/c1-6(9)7-4-2-3-5-8(7)10/h2-5,10h,1h
1-(2-hydroxyphenyl)ethanone
2'-hydroxyacetophenone, reagentplus(r), 99%
2'-hydroxyacetophenone, >=98%
AC-5622
AKOS000118832
2-acetophenol
FT-0669287
FT-0652315
H0192
CHEBI:145716
A801063
A804129
1-(6-hydroxycyclohexa-2,4-dien-1-yl)ethanone;2'-hydroxyacetophenone
104809-67-8
NCGC00248294-01
1-(2-hydroxyphenyl)ethan-1-one
1-(2-hydroxyphenyl)-ethanone
3e533z76w0 ,
4-08-00-00320 (beilstein handbook reference)
unii-3e533z76w0
dtxcid5020285
dtxsid7040285 ,
NCGC00257527-01
cas-118-93-4
tox21_301119
125507-95-1
STL163508
BBL012126
S9375
fema 3548
BP-13220
FT-0612573
PS-3396
AM20060222
SCHEMBL40865
2-hydroxyacetophenone [fhfi]
o-acetyl phenol
paracetamol impurity i [ep impurity]
orthohydroxyacetophenone
1-(2-hydroxy-phenyl)-ethanone
ortho-hydroxyacetophenone
2'-hydroxy-acetophenone
1-(2-hydroxy phenyl)-ethanone
1-(2-hydroxy-phenyl)ethanone
1-(2-hydroxyphenyl)etanone
1-(hydroxyphenyl)ethanone
STR00372
paracetamol impurity i
2-hydroxyacetylbenzene
2'-hydroxyacetophenone (acetaminophen impurity i)
W-108529
CHEMBL3187012 ,
mfcd00002219
bdbm50140214
HY-Y1426
ethanone, 1-(hydroxyphenyl)-
F1908-0162
2'-hydroxyacetophenone, analytical standard
D70588
2'-hydroxyacetophenone, vetec(tm) reagent grade, 98%
1-(2-hydroxyphenyl)ethanone; paracetamol imp. i (ep); 2-hydroxyacetophenone; paracetamol impurity i
2`-hydroxyacetophenone
acetophenone, 2'-hydroxy- (8ci)
1-(2-hydroxyphenyl)ethanone, 9ci
2,4-cyclohexadien-1-one, 6-(1-hydroxyethylidene)- (9ci)
Z57101014
2/'-hydroxyacetophenone
CS-W020051
2'-hydorxyacetophenone
EN300-18385
CCG-266129
Q27257104
2`-hydroxyacetophenone 2-acetylphenol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monohydroxyacetophenoneA hydroxyacetophenone carrying at least one hydroxy substituent.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.58960.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)300.00000.03403.987110.0000AID1272598
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1516692Glutathione reactivity in methanol/PBS assessed as compound-adduct formation at 500 nM measured up to 19 hrs by LC-MS/MS analysis2019Journal of medicinal chemistry, 08-22, Volume: 62, Issue:16
Discovery and Development of a Series of Pyrazolo[3,4-
AID1516690Kinetic solubility of the compound in pH 7.4 PBS by nephelometric method2019Journal of medicinal chemistry, 08-22, Volume: 62, Issue:16
Discovery and Development of a Series of Pyrazolo[3,4-
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID1150146Inhibition of aniline hydroxylase activity of mixed function oxidase system in Wistar rat liver microsomes assessed as conversion of aniline to p-aminophenol after 10 mins1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Inhibitors of hepatic mixed function oxidase. 3. Inhibition of hepatic microsomal aniline hydroxylase and aminopyrine demethylase by 2,6- and 2,4-dihydroxyphenyl alkyl ketones and related compounds.
AID1150147Inhibition of aminopyrine demethylase activity of mixed function oxidase system in Wistar rat liver microsomes assessed as conversion of aminopyrine to 4-aminoantipyrine after 20 mins1977Journal of medicinal chemistry, Sep, Volume: 20, Issue:9
Inhibitors of hepatic mixed function oxidase. 3. Inhibition of hepatic microsomal aniline hydroxylase and aminopyrine demethylase by 2,6- and 2,4-dihydroxyphenyl alkyl ketones and related compounds.
AID1272598Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 20 mins by spectrophotometric method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
One-pot green synthesis of 1,3,5-triarylpentane-1,5-dione and triarylmethane derivatives as a new class of tyrosinase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.90)18.7374
1990's1 (3.45)18.2507
2000's5 (17.24)29.6817
2010's19 (65.52)24.3611
2020's2 (6.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.23 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index70.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]